Your session is about to expire
← Back to Search
Behavioral Intervention
Online Program for Endometriosis Pain
N/A
Recruiting
Led By Caroline Pukall, PhD
Research Sponsored by Dr. Caroline Pukall
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months after the end of the program
Awards & highlights
No Placebo-Only Group
Summary
This trial will test an online program called PelvicSense designed to help people with endometriosis manage their pain. Participants will follow the program remotely and continue their usual treatments. The study aims to see if this program can improve pain and other health outcomes.
Who is the study for?
This trial is for adults over 18 who speak English and have been diagnosed with endometriosis, experiencing pain for at least three months. Participants will continue their usual treatment while being involved in the study.
What is being tested?
The PelvicSense online program's effectiveness on reducing pain and improving sexual outcomes in individuals with endometriosis is being tested. The study spans over a period of six months including assessments before, after the 3-month program, and a follow-up.
What are the potential side effects?
Since PelvicSense is an educational intervention rather than a medication, it may not have typical drug side effects; however, participants might experience discomfort or emotional distress when addressing sensitive topics.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months after the end of the program
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months after the end of the program
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Pain intensity
Secondary study objectives
Pain catastrophizing
Other study objectives
Pain self-efficacy
Sexual distress
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: 3 month PelvicSense(R) programExperimental Treatment1 Intervention
PelvicSense® is a home-based physiotherapy program integrating multiple techniques, including relaxation, breathing, stretching, strengthening and at-home manual therapy. This program also educates participants about the anatomy and physiology of the pelvis and teaches strategies to strengthen the mind-muscle connection to the pelvis.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for endometriosis include hormonal therapies such as estrogen-progestin contraceptives, GnRH agonists and antagonists, and progestins like dienogest. These treatments work by reducing estrogen levels, which in turn decreases the growth and activity of endometrial tissue, thereby alleviating pain and other symptoms.
Behavioral interventions, like the PelvicSense 3-month online program, aim to manage pain through psychological and physical therapy techniques, addressing the chronic pain and improving quality of life. This matters for endometriosis patients as it provides a multifaceted approach to pain management, combining medical and behavioral strategies to enhance overall outcomes.
State of the art, new treatment strategies, and emerging drugs for non-hormonal treatment of endometriosis: a systematic review of randomized control trials.Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist.Pain and endometriosis: Etiology, impact, and therapeutics.
State of the art, new treatment strategies, and emerging drugs for non-hormonal treatment of endometriosis: a systematic review of randomized control trials.Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist.Pain and endometriosis: Etiology, impact, and therapeutics.
Find a Location
Who is running the clinical trial?
Dr. Caroline PukallLead Sponsor
2 Previous Clinical Trials
75 Total Patients Enrolled
Queen's UniversityLead Sponsor
375 Previous Clinical Trials
124,942 Total Patients Enrolled
Caroline Pukall, PhDPrincipal InvestigatorQueen's University
3 Previous Clinical Trials
95 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not fluent in English.I am over 18, speak English, and have been diagnosed with endometriosis for at least 3 months.I am under 18 years old.I have been diagnosed with endometriosis in the last 3 months.
Research Study Groups:
This trial has the following groups:- Group 1: 3 month PelvicSense(R) program
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.